Deutsche Bank’s Repare Therapeutics RPTX Stock Holding History

Deutsche Bank’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,688	Closed	-$39.5K	–	3967
2022 Q4	$39.5K	Buy	+2,688	New	+$40.2K	﹤0.01%	3633

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank's RPTX Position: Q1 2023 in Review

Deutsche Bank sold out of Repare Therapeutics (RPTX) in Q1 2023, closing a stake of 2,688 shares — an estimated $39.5K sold.

Deutsche Bank first reported a position in RPTX in Q4 2022 and held it in 1 quarter. The position peaked at $39.5K in Q4 2022. 77 funds tracked by Wall St. Rank hold RPTX as of Q1 2023.

Deutsche Bank reported no remaining Repare Therapeutics position as of Q1 2023 after selling out during the quarter.
Deutsche Bank sold 2,688 Repare Therapeutics shares in Q1 2023, an estimated $39.5K.
Deutsche Bank first reported a position in Repare Therapeutics in Q4 2022 and held it in 1 quarter.
Deutsche Bank's Repare Therapeutics position peaked at $39.5K in Q4 2022.
77 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.